Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of endocrine responsiveness and adjuvant therapy in very young women (below 35 years) with operable breast cancer and node negative disease.
Colleoni M, Rotmensz N, Peruzzotti G, Maisonneuve P, Orlando L, Ghisini R, Viale G, Pruneri G, Veronesi P, Luini A, Intra M, Cardillo A, Torrisi R, Rocca A, Goldhirsch A. Colleoni M, et al. Among authors: goldhirsch a. Ann Oncol. 2006 Oct;17(10):1497-503. doi: 10.1093/annonc/mdl145. Epub 2006 Jun 23. Ann Oncol. 2006. PMID: 16798834 Free article.
Prediction of response to primary chemotherapy for operable breast cancer.
Colleoni M, Orvieto E, Nolé F, Orlando L, Minchella I, Viale G, Peruzzotti G, Robertson C, Noberasco C, Galimberti V, Sacchini V, Veronesi P, Zurrida S, Orecchia R, Goldhirsch A. Colleoni M, et al. Among authors: goldhirsch a. Eur J Cancer. 1999 Apr;35(4):574-9. doi: 10.1016/s0959-8049(99)00005-2. Eur J Cancer. 1999. PMID: 10492630
Primary chemotherapy in operable breast cancer with favorable prognostic factors: a pilot study evaluating the efficacy of a regimen with a low subjective toxic burden containing vinorelbine, 5-fluorouracil and folinic acid (FLN).
Nolè F, Minchella I, Colleoni M, Orvieto E, Munzone E, de Braud F, Peruzzotti G, Martinelli G, Zampino MG, Catania C, Pizzamiglio M, Veronesi P, Zurrida S, Galimberti V, Goldhirsch A, Veronesi U. Nolè F, et al. Among authors: goldhirsch a. Ann Oncol. 1999 Aug;10(8):993-6. doi: 10.1023/a:1008389106575. Ann Oncol. 1999. PMID: 10509165 Free article. Clinical Trial.
Low-dose oral methotrexate and cyclophosphamide in metastatic breast cancer: antitumor activity and correlation with vascular endothelial growth factor levels.
Colleoni M, Rocca A, Sandri MT, Zorzino L, Masci G, Nolè F, Peruzzotti G, Robertson C, Orlando L, Cinieri S, de BF, Viale G, Goldhirsch A. Colleoni M, et al. Among authors: goldhirsch a. Ann Oncol. 2002 Jan;13(1):73-80. doi: 10.1093/annonc/mdf013. Ann Oncol. 2002. PMID: 11863115 Free article. Clinical Trial.
Recognizing features that are dissimilar in male and female breast cancer: expression of p21Waf1 and p27Kip1 using an immunohistochemical assay.
Curigliano G, Colleoni M, Renne G, Mazzarol G, Gennari R, Peruzzotti G, de Braud E, Robertson C, Maiorano E, Veronesi P, Nolè F, Mandalà M, Ferretti G, Viale G, Goldhirsch A. Curigliano G, et al. Among authors: goldhirsch a. Ann Oncol. 2002 Jun;13(6):895-902. doi: 10.1093/annonc/mdf166. Ann Oncol. 2002. PMID: 12123335 Free article.
Endocrine therapy of breast cancer.
Goldhirsch A, Colleoni M, Gelber RD. Goldhirsch A, et al. Ann Oncol. 2002;13 Suppl 4:61-8. doi: 10.1093/annonc/mdf640. Ann Oncol. 2002. PMID: 12401668 Free article. Review. No abstract available.
718 results